M&A

Varsity-Backed Angels of Care Announces Strategic Partnerships, Expands into Three New States

  • by

Angels of Care, a home health provider that specializes in caring for pediatric patients with complex medical conditions, announced Thursday that it has entered into a strategic partnership with Nursing Solutions and Mission Medstaff. Under terms of the strategic partnership, Nursing Solutions and Mission Medstaff… Read More »Varsity-Backed Angels of Care Announces Strategic Partnerships, Expands into Three New States

StageBio Acquires TPL Path Labs to Expand its Footprints Globally

  • by

Shots: StageBio and TPL Path Labs offers an expanded array of histopathology, molecular pathology, and related solutions to biopharma, medical device and academic researchers across the US, EU, and other countries The acquisition expands StageBio’s pre/ clinical laboratory resources, GLP/GCLP-compliant lab facility and staff in… Read More »StageBio Acquires TPL Path Labs to Expand its Footprints Globally

M&A Experts ‘Can’t Recall a Time When Demand Has Been Higher’ in Sizzling In-Home Care Market

  • by

M&A activity across home health, hospice and in-home care appeared to be “business as usual” at the start of 2020. COVID-19 froze the market in March, however, causing both buyers and sellers to bide their time. But dealmaking action is finally starting to heat up… Read More »M&A Experts ‘Can’t Recall a Time When Demand Has Been Higher’ in Sizzling In-Home Care Market

Medicare Advantage Startup Clover Health Slated to Go Public in a $3.7 Billion SPAC Deal

  • by

Clover Health recently announced that it will go public through a merger with a special purpose acquisition company (SPAC), Social Capital Hedosophia Holdings Corp. III. “Going public will enhance our ability to execute on our mission of improving every life, providing significant capital for the… Read More »Medicare Advantage Startup Clover Health Slated to Go Public in a $3.7 Billion SPAC Deal

STADA Expands its Specialty Footprint with the Acquisition of Lobsor Pharmaceuticals

  • by

Shots:   STADA acquires Lobsar and its innovative therapy to foster its footprints in specialty pharmaceuticals. The acquisition complements STADA’s portfolio and expertise in the treatment of late-stage Parkinson’s disease With the acquisition, STADA gain rights to a triple fixed combination (levodopa/carbidopa/ entacapone) delivered via modern… Read More »STADA Expands its Specialty Footprint with the Acquisition of Lobsor Pharmaceuticals

Bionano Genomics Acquires Lineagen to Facilitate the Clinical Adoption of Saphyr for Digital Cytogenetics

  • by

Shots: Lineagen to receive $9.6M consisting of 6,167,510 shares of Bionano’s common stock, ~ $1.7M in cash and assumption of ~$2.9M in liabilities. The acquisition complements Binano by adding leading cytogeneticists, genetic counselors, laboratory operations and billing experts, clinical commercialization experts, and payor contracts The… Read More »Bionano Genomics Acquires Lineagen to Facilitate the Clinical Adoption of Saphyr for Digital Cytogenetics

The Pennant Group CEO: It’s Too Early to Draw Conclusions About PDGM’s Long-Term Impact

  • by

So far, the transition to the Patient-Driven Groupings Model (PDGM) has gone smoothly for many home health agencies, with a majority successfully avoiding questionable encounters and achieving staffing efficiencies across their operations. Eagle, Idaho-based The Pennant Group Inc. (Nasdaq: PNTG) has seen positive results on… Read More »The Pennant Group CEO: It’s Too Early to Draw Conclusions About PDGM’s Long-Term Impact

Medtronic to Acquire Companion Medical for Adding Smart Insulin Pen to its Diabetes Unit

  • by

Shots: The acquisition will expand Medtronic’s capabilities to serve people using multiple daily injections (MDI) to manage diabetes with the addition of Companion Medical’s InPen to Medtronic’s portfolio. The acquisition is expected to be closed within 1-2mos. Medtronic will advance the automation of insights and… Read More »Medtronic to Acquire Companion Medical for Adding Smart Insulin Pen to its Diabetes Unit

Bayer to Acquire KaNDy Therapeutics for Augmenting its Women’s Healthcare Portfolio

  • by

Shots: KaNDy to receive $425M upfront, ~$450M milestones until launch followed by additional commercial milestones. The transaction is expected to be completed in Sept’2020 The acquisition will add KaNDy’s menopause drug to Bayer’s portfolio. KaNDy has published results of its NT-814 in P-IIb study that… Read More »Bayer to Acquire KaNDy Therapeutics for Augmenting its Women’s Healthcare Portfolio

LHC Group CFO: Historic Home Health Consolidation Opportunity Remains ‘Compelling as Ever’

  • by

Since the worst stretch of the public health emergency, LHC Group Inc. (Nasdaq: LHCG) has seen a decrease in weekly COVID-related missed visits and improved its average daily census. It has also added thousands of new physician referral sources, a win for the company considering… Read More »LHC Group CFO: Historic Home Health Consolidation Opportunity Remains ‘Compelling as Ever’

COVID-19, PDGM to Drive Home Health Deal Activity Up While Pushing Valuations Down

  • by

The COVID-19 emergency has slowed mergers-and-acquisitions activity in the home-based care space, largely due to travel restrictions, general sector uncertainty and the shifting priorities of top leadership. However, interest in home-based care deals remains robust and valuations remain high. In fact, M&A experts expect deal… Read More »COVID-19, PDGM to Drive Home Health Deal Activity Up While Pushing Valuations Down

Humana Helps Fast-Track In-Home Primary Care Company Heal’s Growth with $100M Investment

  • by

Health and well-being company Humana Inc. (NYSE: HUM) has spent the past few years adding to its health care services portfolio while aggressively investing around a home-based care strategy. The Louisville, Kentucky-based company has now revealed its latest step in that direction. On Wednesday, Humana… Read More »Humana Helps Fast-Track In-Home Primary Care Company Heal’s Growth with $100M Investment

Sorrento to Acquire SmartPharm and Develop Pipeline of Gene-Encoded Therapeutic Antibodies Targeting COVID-19 and Cancer

  • by

Shots: Sorrento enters into letter of intent to acquire SmartPharm and develops pipeline of gene-encoded therapeutic Ab, initiating with Sorrento’s STI-1499 or COVI-GUARD, currently preclinical studies with an IND submission targeted for Aug’2020. The transaction is expected to be close in Aug’2020. The integration of… Read More »Sorrento to Acquire SmartPharm and Develop Pipeline of Gene-Encoded Therapeutic Antibodies Targeting COVID-19 and Cancer

Buyer Beware: Factors Home-Based Care Providers Should Consider Before Acquiring PPP Recipients

Pre-coronavirus, the home health and home care industries were already poised for historic consolidation, thanks to the Patient-Driven Groupings Model (PDGM), rising minimum wages and other operational pressures. Industry leaders predict that the COVID-19 emergency will only drive M&A further going forward. However, home-based care… Read More »Buyer Beware: Factors Home-Based Care Providers Should Consider Before Acquiring PPP Recipients